Search -

Displaying 1 - 20 of 52

Sort: Relevancy | Date

Presentation TCT 2024

TCT 242: Prospective Validation of the ARC-HBR, PRECISE-DAPT, and PARIS Risk Prediction Model in the All-Comer PIONEER IV Trial

Presenter: TsungYing Tsai

October 28, 2024

Presentation TCT 2024

From ARC-HBR and PRECISE-DAPT to PRECISE-2: Development and Validation of a Novel Universal Bleeding Risk Score

Presenter: Marco Valgimigli

October 27, 2024

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

News Daily News

Short DAPT May Be Especially Beneficial for Women at High Bleeding Risk

Yael L. Maxwell

November 30, 2023

Presentation TCT 2023

The Primary Endpoint Results from the COMPARE 60/80 HBR Trial: A Randomized Controlled Multi-Center Trial Comparing Ultrathin With Thin Strut Stents in High Bleeding Risk Patients With an Abbreviated DAPT Duration

Presenter: Pieter Smits

October 25, 2023

News Daily News

Clopidogrel Bests Aspirin Monotherapy After PCI Across Risk Strata

Yael L. Maxwell

October 09, 2023

Presentation CTO 2023

CTO and Higher Risk PCI in a HBR Patient: What Should I Be Doing With DAPT +/- Anticoagulation Therapy?

Presenter: Roxana Mehran

February 24, 2023

Presentation TCT 2022

Coronary DCB in HBR Patients: An Alternative to DES?

Presenter: Tuomas Rissanen

September 18, 2022

Presentation TCT 2022

Does It Matter What Stent I Use in a HBR Patient?

Presenter: Pieter Smits

September 18, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2022

Shelley Wood

June 01, 2022

News Conference News EuroPCR 2022

Imaging in PCI for Patients at High Bleeding Risk: Data Point to Possibilities

Caitlin E. Cox

May 25, 2022

News Conference News EuroPCR 2022

Shorter DAPT Sufficient Even in Complex HBR Patients: MASTER DAPT

Yael L. Maxwell

May 17, 2022

Presentation Cardiovascular Interventions 2021

Shortened DAPT after PCI in HBR Patients: How Long and in Which Patients?

Presenter: Ajay J. Kirtane

November 19, 2021

Presentation TCT 2021

Latest Evidence on Short DAPT & HBR Patients

Presenter: Rafael Cavalcante

November 06, 2021

News Conference News TCT 2021

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Shelley Wood

November 05, 2021

Presentation TCT 2021

Latest HBR Clinical Evidence

Presenter: Marco Valgimigli

November 04, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for August 2021

Shelley Wood

September 03, 2021

News Conference News ESC 2021

OAC Analysis From MASTER DAPT Raises No Red Flags for Shorter DAPT

Shelley Wood

September 02, 2021

News Conference News ESC 2021

MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk

Shelley Wood

August 28, 2021

News Conference News EAS 2021

High Ischemic Risk and Bleeding Risk: A Delicate Balance Post-PCI

Michael O'Riordan

June 08, 2021

Advertisement

TCT 242: Prospective Validation of the ARC-HBR, PRECISE-DAPT, and PARIS Risk Prediction Model in the All-Comer PIONEER IV Trial

From ARC-HBR and PRECISE-DAPT to PRECISE-2: Development and Validation of a Novel Universal Bleeding Risk Score

May 2024 Dispatch for the CV Team

Short DAPT May Be Especially Beneficial for Women at High Bleeding Risk

The Primary Endpoint Results from the COMPARE 60/80 HBR Trial: A Randomized Controlled Multi-Center Trial Comparing Ultrathin With Thin Strut Stents in High Bleeding Risk Patients With an Abbreviated DAPT Duration

Clopidogrel Bests Aspirin Monotherapy After PCI Across Risk Strata

CTO and Higher Risk PCI in a HBR Patient: What Should I Be Doing With DAPT +/- Anticoagulation Therapy?

Coronary DCB in HBR Patients: An Alternative to DES?

Does It Matter What Stent I Use in a HBR Patient?

TCTMD’s Top 10 Most Popular Stories for May 2022

Imaging in PCI for Patients at High Bleeding Risk: Data Point to Possibilities

Shorter DAPT Sufficient Even in Complex HBR Patients: MASTER DAPT

Shortened DAPT after PCI in HBR Patients: How Long and in Which Patients?

Latest Evidence on Short DAPT & HBR Patients

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Latest HBR Clinical Evidence

TCTMD’s Top 10 Most Popular Stories for August 2021

OAC Analysis From MASTER DAPT Raises No Red Flags for Shorter DAPT

MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk

High Ischemic Risk and Bleeding Risk: A Delicate Balance Post-PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content